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The mechanism of fatty acid uptake is of high interest for basic research and clinical
interventions. Recently, we showed that mammalian long chain fatty acyl-CoA synthetases
(ACS) are not only essential enzymes for lipid metabolism but are also involved in
cellular fatty acid uptake. Overexpression, RNAi depletion or hormonal stimulation of ACS
enzymes lead to corresponding changes of fatty acid uptake. Remarkably, ACS are not
localized to the plasma membrane where fatty acids are entering the cell, but are found
instead at the endoplasmic reticulum (ER) or other intracellular organelles like mitochondria
and lipid droplets. This is in contrast to current models suggesting that ACS enzymes
function in complex with transporters at the cell surface. Drawing on recent insights
into non-vesicular lipid transport, we suggest a revised model for the cellular fatty acid
uptake of mammalian cells which incorporates trafficking of fatty acids across membrane
junctions. Intracellular ACS enzymes are then metabolically trapping fatty acids as acyl-CoA
derivatives. These local decreases in fatty acid concentration will unbalance the equilibrium
of fatty acids across the plasma membrane, and thus provide a driving force for fatty acid
uptake.
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Fatty acid uptake and metabolism are exciting areas of research
for two main reasons. First, many open questions and conflict-
ing ideas stimulate basic research aimed at elucidating molecular
mechanisms and their regulation. Second, lipids are critical for
human health, and widespread diseases like diabetes type 2 and
atherosclerosis are tightly linked to the dysregulation of lipid
metabolism. Here, we take a closer look at a family of essential
enzymes which are necessary for the initial stages of fatty acid
metabolism. Taking recent experimental evidence into account,
we are suggesting a new paradigm for fatty acid uptake based on
metabolic trapping across closely spaced intracellular membrane
junctions.
ACYL-CoA SYNTHETASES ARE ESSENTIAL ENZYMES OF
LIPID METABOLISM
Long chain fatty acids are the main building blocks of mem-
brane lipids, and as such essential for cellular life as we know it.
Furthermore, the oxidation of fatty acids generates two times
more energy than other nutrients like sugars or amino acids.
Neutral lipids synthesized from fatty acids are efficiently stored in
lipid droplets, sustaining life when nutrients in the outside world
are diminishing. For all these processes, fatty acids need to be
chemically “activated” by the esterification with coenzyme A. The
enzymes catalyzing this process are the fatty acyl-CoA synthetases
(ACS), and the 26 human enzymes are grouped based on the
chain length of their fatty acid substrates (Watkins et al., 2007).
The five ACSL and six ACSVL (acyl-CoA synthetase for long/very
long chain fatty acids) family proteins are especially physiologi-
cally relevant. All of these 11 enzymes will activate common fatty
acids like palmitate and oleate; ACSVL proteins are also capable
of esterifying the far less abundant fatty acids with 24 and more
carbon atoms. ACSVL enzymes are also known as fatty acid trans-
port proteins (FATPs); this functional assignment is mainly based
on the correlation between their expression and cellular fatty acid
uptake, and the initially reported localization to the cell surface
(Schaffer and Lodish, 1994).
CELLULAR FATTY ACID UPTAKE IS DRIVEN INDIRECTLY BY
INTRACELLULAR ACYL-CoA SYNTHETASES
Our initial studies were focused on the function of FATP4 in
fatty acid uptake. Unexpectedly, we found that FATP4 localized
to the endoplasmic reticulum (ER) by a variety of independent
approaches, including the identification of a novel ER target-
ing motif (Milger et al., 2006). Nevertheless, overexpression lead
to increased cellular fatty acid uptake suggesting an indirect
influence of FATP4. A point mutation inactivating the acyl-CoA
synthetase activity of FATP4 abolished any effects on fatty acid
uptake. This lead us to conclude that FATP4 functions as an ER-
localized enzyme, and that this metabolic function is sufficient to
increase fatty acid transport. That this could be a general mecha-
nism was supported by our parallel studies on ACSL1 which was
localized to mitochondria but also increased fatty acid uptake
when overexpressed (Milger et al., 2006). Unfortunately, our
results were met with considerable skepticism since other studies
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had reported a plasma membrane location for ACSL1 and FATP4
(Gargiulo et al., 1999; Stahl et al., 1999). In addition, it was argued
that some invisible/undetectable fraction of FATP4 at the plasma
membrane could be responsible for all the effects on fatty acid
uptake.
Inspired by the differential localization of FATP4 and ACSL1
we then analyzed the subcellular distribution of the other
ACS(V)L enzymes (Becker et al., 2007). ACSL3 showed a unique
localization to lipid droplets, in addition to the ER. Since ACSL3
had never been observed at the cell surface or suggested to be a
transporter protein, this presented us with a fresh opportunity to
test our findings again. Depletion of ACSL3 by RNAi diminished
fatty acid uptake whereas overexpression had the opposite effect
(Poppelreuther et al., 2012). Further work on FATP2 (Krammer
et al., 2011) and FATP1 (Zhan et al., 2012) as well as data from
other labs (reviewed by Mashek and Coleman, 2006; Digel et al.,
2009) are in line with this. Summarizing, we would argue that
by now there is sufficient and compelling evidence that intra-
cellular acyl-CoA synthetases are indirectly regulating fatty acid
uptake.
Cells do not overexpress, knockout or inhibit their acyl-CoA
synthetases, which places of course restrictions on the interpre-
tation of the results obtained by these approaches. However, cells
and organisms do respond to fasting and refeeding by changing
the expression level of ACS(V)L enzymes (e.g., Mashek et al.,
2006; Xu et al., 2012). In addition, acute upregulation of the
ACS activity of FATP4 by insulin was recently demonstrated
(Digel et al., 2011), concomitant with increased fatty acid uptake.
We carefully confirmed the localization of FATP4 to the ER
after insulin treatment. This was necessary because the related
FATP1 enzyme had been suggested to move to the plasma mem-
brane in response to insulin and then start acting to work as a
fatty acid transporter (Wu et al., 2006). Since FATP4 remained
at the ER, and the enhanced fatty acid uptake was correlated
to the wortmannin-sensitive increase of the ACS activity, we
finally suggested to use the name ACSVL4 in preference over
FATP4.
When we compared the endogenous ACS activity to the
fatty acid uptake of C2C12 muscle cells, we were quite sur-
prised to learn that the enzyme activity appears to be in vast
excess (50–80×) over what is actually needed to esterify all
incoming fatty acids (Digel et al., 2011). Nevertheless, C2C12
cells overexpressing ACSVL4/FATP4 showed a 2-fold increase in
fatty acid uptake which corresponded well to the 2-fold higher
enzyme activity of these cells (Digel et al., 2011). This suggests
that the increased enzyme activity conferred by overexpressed
ACSVL4/FATP4 is transmitted to the fatty acid uptake machinery
in an attenuated but still proportional manner.
We consider it unfortunate that “transport” and “uptake”
are often used synonymously. Here, we use “transport” for the
movement of a fatty acid from the extracellular side across
the plasma membrane to the cytosol. Uptake comprises both
the transport and the esterification step which is trapping the
fatty acids inside the cell. Therefore, significant uptake requires
the presence of acyl-CoA synthetases. This was nicely exem-
plified for adipocytes, where inhibition of the acyl-CoA syn-
thetases by the fungal metabolite triacsin C reduced fatty acid
uptake to background levels (Richards et al., 2006). While it
is well established that fatty acid binding proteins (FABPs)
at the cell surface somehow facilitate fatty acid uptake, the
mechanism(s) are not yet clear (Glatz et al., 2010). The
term “transporter” is often applied liberally for these proteins
even if none of them has been shown to actually transport
fatty acids, which tends to confuse researchers outside the
field.
ER-PLASMA MEMBRANE JUNCTIONS ALLOW EFFICIENT
LIPID TRANSFER ACROSS THE CYTOSOL
Subcellular membranes differ widely in their lipid composition,
and three principal mechanisms account for the sorting and
trafficking of the individual lipid molecules: vesicular traffic, dif-
fusion across the cytosol, and exchange mediated by lipid transfer
proteins (LTPs). Nonvesicular lipid trafficking is a rising field of
research with many divergent ideas, but there is common agree-
ment that lipid transport will only be efficient when donor and
acceptor membranes are closely apposed (Levine and Loewen,
2006; Prinz, 2010). The distances observed range from 7nm
to 33 nm, and the structures themselves are termed membrane
junctions or membrane contact sites.
The amount of ER-plasma membrane junctions varies among
eukaryotic cells but may be extensive (Friedman and Voeltz,
2011). A bridging protein adroitly termed junctophilin has been
identified for the highly specialized ER-plasma membrane junc-
tion of skeletal muscle cells, but putative structural proteins
of membrane junctions in other cell types still await their
identification (reviewed by Lev, 2010; Carrasco and Meyer,
2011).
LTPs bind to the two membranes simultaneously or sequen-
tially, and may include a diffusion step across the narrow space as
part of their itinerary. Recent overviews show an already impres-
sive list of LTPs grouped into several subfamilies (D’Angelo et al.,
2008), but appear to be focused on classical membrane lipids. We
would like to suggest here to include the well characterized family
of FABPs even if fatty acids are only transient or minor compo-
nents of cellular membranes. FABPs are small cytosolic proteins
and have been reviewed extensively for their lipid transfer capabil-
ities (Storch and Thumser, 2000; Haunerland and Spener, 2004;
Furuhashi and Hotamisligil, 2008).
A NEWMODEL FOR THE MOLECULAR MECHANISM OF
CELLULAR FATTY ACID UPTAKE
Three main models are discussed regarding the mechanism of
fatty acid transport across the plasma membrane: unassisted dif-
fusion through membranes, protein mediated transport, and
protein facilitated diffusion. This has been debated intensely in
recent years, but is beyond the scope of our perspective here.
Please see (Hamilton et al., 2002; Kampf and Kleinfeld, 2007;
Glatz et al., 2010), and references therein.
A current model for the uptake process is the vectorial acy-
lation hypothesis which states that transport and activation are
functionally coupled to each other. A protein complex located
at the plasma membrane has been suggested to promote vecto-
rial acylation (Black and Dirusso, 2003; Richards et al., 2006).
One protein would function primarily or even exclusively as
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a transporter (mammalian FATP1/ACSVL1, or yeast Fat1p),
whereas the second protein would be an enzyme trapping the
fatty acids by esterification with coenzyme A. We agree that
the trapping of fatty acids by acyl-CoA synthetases is a cru-
cial step in the uptake process. However, according to our data
the ACSVL/FATP proteins are localized intracellularly to the ER
(or to other internal membranes), and therefore cannot trans-
port fatty acids across the plasma membrane. Among the other
mammalian ACSL enzymes, ACSL1 has been repeatedly sug-
gested to take over the enzyme function at the plasma mem-
brane localized vectorial acylation complex (Gargiulo et al., 1999;
Richards et al., 2006), but we found this protein on mitochon-
dria in many different cell types. In conclusion, our results
on the localization of acyl-CoA synthetases in mammalian cells
do not support a vectorial acylation complex at the plasma
membrane.
How then do we envisage that fatty acid uptake is organized?
As outlined in Figure 1, we suggest that the transport of fatty
acids across a cytosolic gap is an essential part of the uptake pro-
cess. Plasma membrane associated FABPs oriented toward the
extracellular side may facilitate the transport of fatty acids by
accumulating them close to the lipid bilayer, and CD36 is a candi-
date for this process (Glatz et al., 2010). Being close to the plasma
membrane, the fatty acid will spontaneously integrate into the
extracellular leaflet, and flip–flop to the cytosolic side. It is pos-
sible that these processes are enhanced by membrane associated
proteins. From here on we envisage three different routes for the
fatty acid to reach an acyl-CoA synthetase located on a differ-
ent membrane system. In common, these routes have to be short
to be efficient, and this is very likely realized by the formation
of membrane junctions between the plasma membrane and the
ER. Fatty acids may spontaneously diffuse across the cytosolic
space to be integrated in the cytosolic leaflet of the ER (route A).
FABPs are protecting the hydrophobic tail of the fatty acids from
the aqueous environment of the cytosol and will act as transfer
proteins (route B). Finally, dedicated fatty acid transfer proteins
anchored to both types of membrane may equilibrate fatty acids
by a picking up-delivery mechanism (route C). These possibili-
ties are not mutually exclusive but would differ significantly in
the time scales required, with fatty acid transfer proteins offer-
ing the fasted transport rates. After reaching the ER, fatty acids
will rapidly equilibrate by lateral diffusion. Finally, fatty acids will
FIGURE 1 | Membrane junctions enable the metabolic trapping of fatty
acids by intracellular acyl-CoA synthetases. Fatty acids from the
extracellular space become integrated into the plasma membrane, which
is likely facilitated by plasma membrane associated fatty acid binding
proteins (light blue). Transport of fatty acids between the plasma
membrane and the endoplasmic reticulum (and other intracellular
organelles) may be organized by three different pathways. (A) Fatty acids
diffuse spontaneously across the narrow membrane junction. (B) Cytosolic
fatty acid binding proteins (dark green) may act as lipid chaperones to
increase transport rates between different membranes. (C) Fatty acid
transfer proteins (orange) may transport molecules by conformational
changes rather than diffusion. Fatty acids delivered to the ER will rapidly
equilibrate by lateral diffusion, and finally be esterified by acyl-CoA
synthetases (ACS). An increase in ACS activity will lead to a relative
depletion of fatty acids from the ER, and this change in the concentration
gradient will be transmitted ultimately to the extracellular space, providing
the driving force for fatty acid uptake. PM plasma membrane, ER
endoplasmic reticulum, ACS acyl-CoA synthetase.
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enter the catalytic site of an acyl-CoA synthetase from the mem-
brane side (Hisanaga et al., 2004; Forneris and Mattevi, 2008).
Since the ER is an extensive membrane system in contact with
all other subcellular organelles, it may also serve as a “highway”
to transport fatty acids efficiently to other membranes (Holthuis
and Levine, 2005).
It is important to note that all three routes will try to equi-
librate the concentration of fatty acids between the different
membrane systems. Consequently, the activation of an acyl-CoA
synthetase will transiently deplete fatty acids in the ER mem-
brane. This relative deficiency will be short-lived because of the
rapid compensation from the plasma membrane and ultimately
from the extracellular environment.
Why such a complicated itinerary? We have to admit that plac-
ing a trapping enzyme directly at the plasma membrane appears
superior to our model proposed here. However, our experi-
mental data leave no room for this. A benefit of our model
is that it offers more options for the regulation of fatty acid
uptake. Moreover, ACS family proteins might form complexes
with fatty acyl transferases, especially at the ER. This would ensure
timely and efficient usage of acyl-CoA molecules, before they are
hydrolyzed by thioesterases.
In summary, metabolic trapping of fatty acids at inter-
nal membranes, especially the ER will create an intracellular
concentration gradient which is the ultimate driving force for
cellular fatty acid uptake. It is likely that membrane junctions
are required for the efficient transfer of fatty acids between the
plasma membrane and the ER. Metabolic trapping by enzymes
on intracellular organelles rather than vectorial acylation at the
plasma membrane account for the fatty acid uptake of mam-
malian cells.
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